FIGURE 3 from Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis

Armin Rashidi,Maryam Ebadi,Tauseef U. Rehman,Heba Elhusseini,David Kazadi,Hossam Halaweish,Mohammad H. Khan,Andrea Hoeschen,Qing Cao,Xianghua Luo,Amanda J. Kabage,Sharon Lopez,Sivapriya Ramamoorthy,Shernan G. Holtan,Daniel J. Weisdorf,Alexander Khoruts,Christopher Staley

DOI: https://doi.org/10.1158/2767-9764.26004705

2024-01-01

Abstract:Faecalibacterium and aGVHD risk. A, log-ratio lasso regression to find early post-FMT/placebo, genus-level, gut microbiota predictors of grade II–IV aGVHD. The y axis shows taxa in the final model. The probability for each taxon of being selected in the final model is shown along the x-axis. This probability is calculated from 100 4-fold cross-validated runs. Positive/negative signs show positive/negative associations, and the value (indicated by a color gradient) represents the strength of association. B, Comparison between early post-FMT versus early post-placebo samples in Faecalibacterium abundance. C, Comparison between the groups developing versus not developing grade II–IV aGVHD in early post-FMT/placebo Faecalibacterium abundance. D,Faecalibacterium abundance at pre-FMT/placebo and early post-FMT/placebo timepoints. Samples from the same patient are connected, with line type indicating randomized treatment arm and line color showing future grade II–IV aGVHD status. E,Faecalibacterium abundance in FMT donor samples and patient samples according to treatment arm and timepoint. F, Relationship between Faecalibacterium abundance change (pre- to post-FMT) and ASV-level binary similarity of early post-FMT versus donor composition of this genus. The gray shaded area shows the 95% confidence interval. Higher post-FMT Faecalibacterium abundance was strongly associated with a greater similarity between post-FMT sample and donor composition in Faecalibacterium ASVs (a simple measure of engraftment). G,Faecalibacterium change from pre-FMT to early post-FMT timepoints per FMT donor. Each box in B, C, and G shows the median (horizontal middle line) and interquartile range. Whisker lines indicate nonoutlier maximum and minimum values. A small jitter is included for better visualization. P values in B and C are from a Wilcoxon test and in G from a Kruskal–Wallis test. aGVHD: acute graft-versus-host disease; FMT: fecal microbiota transplantation.